Back to Journals » Lung Cancer: Targets and Therapy » Volume 1 » Default

Circulating tumor cells (CTCs) in lung cancer: current status and future perspectives

Authors Tanaka F, Yoneda K, Hasegawa S

Published 7 July 2010 Volume 2010:1(Default) Pages 77—84

DOI https://doi.org/10.2147/LCTT.S6828

Review by Single-blind

Peer reviewer comments 2


Fumihiro Tanaka, Kazue Yoneda, Seiki Hasegawa

Department of Thoracic Surgery, Hyogo College of Medicine, Nishinomiya-city, Hyogo, Japan

Abstract: Primary lung cancer is the leading cause of cancer-related deaths in most industrialized countries, and it is important to detect and control metastases distant from the lungs for improvement of a patient’s prognosis. Circulating tumor cells (CTCs) are tumor cells that are shed from the primary site and circulate in the peripheral blood, and recent studies have shown that CTCs can be useful clinical markers in some solid tumors such as those of breast cancer. In primary lung cancer, the clinical significance of CTCs remains unclear, but some promising results have been recently reported. Here, we reviewed the current status and future perspectives of CTCs in primary lung cancer.

Keywords: metastasis, cellsearch, CTC-chip, tumor cells

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]